chr16-83968680-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_019065.3(NECAB2):c.32C>T(p.Ala11Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000105 in 988,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019065.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NECAB2 | NM_019065.3 | c.32C>T | p.Ala11Val | missense_variant | 1/13 | ENST00000305202.9 | |
NECAB2 | NM_001329748.1 | c.32C>T | p.Ala11Val | missense_variant | 1/12 | ||
NECAB2 | NM_001329749.2 | c.-192C>T | 5_prime_UTR_variant | 1/12 | |||
NECAB2 | XM_047434240.1 | c.-23+3444C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NECAB2 | ENST00000305202.9 | c.32C>T | p.Ala11Val | missense_variant | 1/13 | 1 | NM_019065.3 | P1 | |
NECAB2 | ENST00000681513.1 | n.437C>T | non_coding_transcript_exon_variant | 1/13 |
Frequencies
GnomAD3 genomes AF: 0.000515 AC: 75AN: 145634Hom.: 0 Cov.: 30
GnomAD4 exome AF: 0.0000344 AC: 29AN: 842354Hom.: 0 Cov.: 31 AF XY: 0.0000282 AC XY: 11AN XY: 390000
GnomAD4 genome AF: 0.000515 AC: 75AN: 145722Hom.: 0 Cov.: 30 AF XY: 0.000466 AC XY: 33AN XY: 70862
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.32C>T (p.A11V) alteration is located in exon 1 (coding exon 1) of the NECAB2 gene. This alteration results from a C to T substitution at nucleotide position 32, causing the alanine (A) at amino acid position 11 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at